Screener
Vericel VCEL Epicel — Product sales, net
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vericel in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Vericel’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 8:49 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050836
| Revenue by product (in thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Change in estimates related to prior periods (e) | 211 | 804 | 82 | 1,735 |
| Total MACI implants, kits, and instruments | 65,506 | 53,458 | 121,904 | 99,755 |
| Epicel | ||||
| Direct bill (hospital) | 10,404 | 8,614 | 21,289 | 13,578 |
| NexoBrid | 1,547 | 1,168 | 2,689 | 2,505 |
| Total revenue | $77,457 | $63,240 | $145,882 | $115,838 |
| (a) Represents implants sold through Orsini and AllCare whereby such specialty pharmacies have a direct contract with the underlying insurance provider. The amount of reimbursement is based on contracted rates at the time of sale supported by the pharmacy’s direct contracts. | ||||
| (b) Represents implants sold through Orsini and AllCare whereby such specialty pharmacy does not have a direct contract with the underlying payer and is subject to third-party reimbursement. The amount of reimbursement is established based on publicly available rates, fee schedules or past payer precedents. |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Vericel's epicel — product sales, net?
- Vericel (VCEL) reported epicel — product sales, net of $10.4M in Q2 2026.
- How has Vericel's epicel — product sales, net changed year-over-year?
- Vericel's epicel — product sales, net increased by 20.8% year-over-year, from $8.61M to $10.4M.
- What is the long-term trend for Vericel's epicel — product sales, net?
- Over 4 years (2021 to 2025), Vericel's epicel — product sales, net has grown at a -6.3% compound annual growth rate (CAGR), from $41.52M to $32.07M.
- What does epicel — product sales, net mean?
- Represents the total net revenue generated from the sale of the Epicel product line after accounting for returns, allowances, and discounts. This metric serves as a primary indicator of market demand and commercial adoption for this specific therapeutic offering. Tracking these sales provides insight into the product's lifecycle performance and its contribution to the company's overall top-line growth.
Ask your AI about Vericel's epicel — product sales, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude